These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
13. [Screening for elevated creatine kinase activities for the early diagnosis of Duchenne muscular dystrophy]. Beckmann R, Scheuerbrandt G. Fortschr Med; 1979 Oct 18; 97(39):1733-6. PubMed ID: 511067 [Abstract] [Full Text] [Related]
14. Clinical investigation in Duchenne dystrophy: V. Use of creatine kinase and pyruvate kinase in carrier detection. Griggs RC, Mendell JR, Brooke MH, Fenichel GM, Miller JP, Province M, Moxley RT, Huntzinger D, Vaughn A, Cohen M. Muscle Nerve; 1985 Jan 18; 8(1):60-7. PubMed ID: 4058458 [Abstract] [Full Text] [Related]
16. Duchenne muscular dystrophy carrier detection using logistic discrimination: serum creatine kinase and hemopexin in combination. Percy ME, Andrews DF, Thompson MW. Am J Med Genet; 1981 Jan 18; 8(4):397-409. PubMed ID: 7246612 [Abstract] [Full Text] [Related]
17. Carrier detection in Duchenne muscular dystrophy. Evidence from a study of obligatory carriers and mothers of isolated cases. Sibert JR, Harper PS, Thompson RJ, Newcombe RG. Arch Dis Child; 1979 Jul 18; 54(7):534-7. PubMed ID: 485196 [Abstract] [Full Text] [Related]
18. Use of dystrophin genomic and cDNA probes for solving difficulties in carrier detection and prenatal diagnosis of Duchenne muscular dystrophy. Shomrat R, Driks N, Legum C, Shiloh Y. Am J Med Genet; 1992 Feb 01; 42(3):281-7. PubMed ID: 1536162 [Abstract] [Full Text] [Related]
19. Detection of preclinical Duchenne muscular dystrophy and its female carriers. Beckmann R. Isr J Med Sci; 1977 Feb 01; 13(2):102-6. PubMed ID: 863671 [No Abstract] [Full Text] [Related]
20. Creatine-kinase and pyruvate-kinase activities in normal children: implications in Duchenne muscular dystrophy carrier detection. Passos MR, Gonzalez CH, Zatz M. Am J Med Genet; 1985 Oct 01; 22(2):255-62. PubMed ID: 4050856 [Abstract] [Full Text] [Related] Page: [Next] [New Search]